Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2447141000168111 | Ursodeoxycholic Acid (LAPL) (ursodeoxycholic acid 250 mg) capsule, 60 capsules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2447151000168113 | Ursodeoxycholic Acid (LAPL) 250 mg capsule, 60 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ursodeoxycholic Acid (LAPL) 250 mg capsule, 60 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Ursodeoxycholic Acid (LAPL) 250 mg capsule, 60 | Is a | ursodeoxycholic acid 250 mg capsule, 60 | true | Inferred relationship | Some | ||
| Ursodeoxycholic Acid (LAPL) 250 mg capsule, 60 | has TPUU | Ursodeoxycholic Acid (LAPL) 250 mg capsule | true | Inferred relationship | Some | 1 | |
| Ursodeoxycholic Acid (LAPL) 250 mg capsule, 60 | has TP | Ursodeoxycholic Acid (LAPL) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ursodeoxycholic Acid (LAPL) 250 mg capsule, 60, blister pack | Is a | True | Ursodeoxycholic Acid (LAPL) 250 mg capsule, 60 | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product pack reference set
FHIR